Evotec

Impact: Evotec has nominated Dieter Weinand as the new Chairman of its Supervisory Board, aiming to strengthen commercial execution, strategic partnerships, and profitability. This move is part of Evotec's transformation into a more efficient and focused company.

Impact: Evotec appointed Dr. Ingrid Müller as its Chief Operating Officer, which is expected to strengthen its global operations and growth transformation.

Impact: Evotec SE is the issuer of the shares whose voting rights are being reported. The changes in holdings by Goldman Sachs>>> affect the ownership structure of Evotec>>>.

Impact: Evotec SE launched J.TRAIN, a new service offering through its wholly-owned subsidiary Evotec — Just – Evotec Biologics, which is expected to increase its revenue streams and market position in biologics manufacturing. This strategic expansion validates its technology licensing model and enhances its service portfolio.

Impact: Evotec SE is the issuer whose voting rights are being reported. The changes in shareholding by Goldman Sachs, Inc. reflect investor interest and potential shifts in control, which can influence its stock performance.